The potential mechanisms driving aberrant expression of Bcl-2 proteins in tumor cells are diverse and may include gene amplification, epigenetic changes, posttranslational modifications as well as overactivation of upstream transcription factors (e.g. NFκB. Here, NFKB1 is linked to neoplasm.